| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.15 | 0.009 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.009 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |